The preclinical discovery and clinical development of ciltacabtagene autoleucel (Cilta-cel) for the treatment of multiple myeloma
.
Source: Expert Opinion on Drug Discovery - Category: Drugs & Pharmacology Authors: Irene StrasslKlaus Podara Division of Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Department of Internal Medicine I, Ordensklinikum Linz Hospital, Linz, Austriab Medical Faculty, Johannes Kepler University Linz, Linz, A Source Type: research
More News: Cancer & Oncology | Drugs & Pharmacology | Hematology | Hospitals | Internal Medicine | Myeloma | Stem Cell Therapy | Stem Cells | Transplants